Cytiva is a biotechnology company based in Uppsala, recognized for its extensive portfolio of life sciences brands, which includes ÄKTA, Amersham, HyClone, MabSelect, and Whatman. The company specializes in providing comprehensive solutions and services tailored to the biopharmaceutical sector, focusing on accelerating the development of therapeutics. Cytiva's offerings are designed to support various stages of the biopharma journey, addressing the needs of researchers and manufacturers alike.
In addition to its product offerings, Cytiva is committed to workforce development, providing resources for upskilling professionals in the life sciences field. The company emphasizes sustainability in its operations and engages with the latest news and developments within the industry. Cytiva also provides access to the 2025 Global Biopharma Index and facilitates knowledge-sharing platforms to enhance industry insights, reflecting its dedication to being a part of transformative advancements in healthcare.